Bioventus Inc.BVSNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank78
3Y CAGR+19.3%
5Y CAGR-10.0%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
+19.3%/yr
vs -8.3%/yr prior
5Y CAGR
-10.0%/yr
Recent acceleration
Acceleration
+27.6pp
Accelerating
Percentile
P78
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$51.24M+23.2%
2024$41.58M+12.5%
2023$36.96M+22.5%
2022$30.19M-31.3%
2021$43.93M-49.4%
2020$86.84M+34.6%
2019$64.52M+50.8%
2018$42.77M+764.1%
2015$4.95M-68.6%
2014$15.77M-